Search results
Cancer 'super tests' screen for more than 50 cancers. But are they saving lives?
WBUR Boston· 3 days agoWhat if there were a screening test to check for cancers — more than 50 of them — with a single...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 4 days agoSanta Barbara, CA, May 21, 2024 (GLOBE NEWSWIRE) -- CancerVax, Inc., the developer of breakthrough cancer drugs that will use the body’s immune system to fight cancer, today announced that its ...
If I'm diagnosed with one cancer, am I likely to get another?
Medical Xpress· 7 days agoFear of cancer returning is one of the top health concerns. While initial cancer treatment may seem...
Breast cancer ‘immunity’ for survivors could be achieved by killing ‘undruggable’ cells
Daily Telegraph· 2 days agoAround 10 per cent of survivors will suffer a relapse, but this increases to 40 per cent among...
New study shows how cancer cells exploit the immune system
Medical Xpress· 3 days agoThis latest research, published in Immunity and led by Peter Mac's Group Leader Dr. Ian Parish, has discovered a second brake on the immune system called tolerance where cancer cells effectively ...
NCI-MATCH Precision Medicine Clinical Trial
National Cancer Institute· 2 days agoNCI-MATCH, also known as MATCH, is a precision medicine cancer treatment clinical trial that sought to find out if treating cancer based on specific...
Scholarship recipient continues OSU-Marion's tradition of research excellence
The Marion Star via Yahoo News· 4 days agoOhio State Marion junior biology major Wesley Bush was named a Pelotonia Undergraduate Scholar by...
Pharma Co. Will Face Unjust Enrichment Claim Over 'Immortal' HeLa Cells | Law.com
Law.com· 4 days agoAn unjust enrichment filed by the grandson of Henrietta Lacks, a Black woman whose cervical cancer...
Keeping CAR T Cells Sharp
The Scientist· 4 days agoChimeric antigen receptor (CAR) T cells have a tough job. Engineered with a receptor that recognizes molecules decorating the surface of cancer cells,...
Tango terminates USP1 inhibitor programme
Clinical Trials Arena via Yahoo Finance· 1 day agoTango Therapeutics has terminated the development of its TNG348 programme after data emerged from the Phase I/II trial showing that the therapy may cause...
